NCT07587827
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07587827
Title Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer (ODI-2001-01)
Acronym ODI-2001-01
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Centre Georges Francois Leclerc
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.